Young adults starting treatment between ages 25-34 could gain nearly two years of life expectancy, spend nearly six fewer years with diabetes, and reduce their risk of hypertension, heart disease, stroke and cancer
This combination approach is theoretically sound but has not been formally studied
GLP-1 drugs imitate a natural hormone that is released after eating
This makes it ideal for intravenous applications where you want to avoid shocking cells with a sudden change in osmotic pressure
Best choice: your provider can recommend the right option based on your B12 level, the cause of your deficiency, and your symptoms
Research indicates the peptide induces mediator release in mast cells, with effects observed at concentrations between 0.2-2000 nM